Showing posts with label Diabetes. Show all posts
Showing posts with label Diabetes. Show all posts
Friday, July 1, 2011

New study singles out factors linked to cognitive deficits in type 2 diabetes

ScienceDaily (Sep. 11, 2010) — Older adults with diabetes who have high blood pressure, walk slowly or lose their balance, or believe they're in bad health, are significantly more likely to have weaker memory and slower, more rigid cognitive processing than those without these problems, according to a new study published by the American Psychological Association.

These three health factors stood out from more than a dozen suspected to shape how Type 2 diabetes is frequently shadowed by cognitive impairment, including dementia. An analysis in September's Neuropsychology stresses that although these factors might not actually cause cognitive problems, their presence can warn doctors that such problems may exist or soon develop.

"Awareness of the link between diabetes and cognition could help people realize how important it is to manage this disease--and to motivate them to do so," said co-author Roger Dixon, PhD, of the University of Alberta.

Type 2 diabetes has been found by other researchers to nearly double the risk of dementia and Alzheimer's disease, said Dixon, who studies how health affects cognition in aging. As diabetes becomes more common, this heightened risk could dramatically hike the number of older people with dementia -- a double whammy of serious chronic disease. Among people older than 60, the U.S. prevalence of Type 2 diabetes is more than 23 percent, according to the National Institute of Diabetes and Digestive & Kidney Diseases. The Canadian prevalence is nearly 19 percent, according to the Public Health Agency of Canada.

An analysis of older Canadians living in British Columbia -- 41 with Type 2 diabetes (ages 55-81) and 458 matched healthy controls (ages 53-90) -- found that systolic blood pressure (the top number, or maximum pressure on artery walls during a single heartbeat), a low combination score for gait and balance, and a patient's own reports of poor health all played a statistically significant role in the relationship between diabetes and cognitive impairment relationship.

In other words, higher but still normal blood pressure, slower gait and shakier balance, and/or reporting one's self to be in bad health regardless of actual problems boosted the likelihood that someone with Type 2 diabetes had impaired cognition. The relationships were linear: For example, the worse the balance, the higher the likelihood of cognitive problems, as measured by mental speed (reaction time, switching time and perceptual speed), mental control and flexibility (executive functioning), and recall of recent learning (episodic memory).

The results highlight factors that may work indirectly, gradually and cumulatively to make older diabetics more likely to develop dementia. Researchers tested 13 different variables in all, in the areas of general fitness, emotional health, subjective and functional health, and lifestyle activities.

Mediating Factors

Because diabetes and hypertension often go together, Dixon said he was not surprised that high systolic blood pressure accounted for one-third to one-half of significantly worse scores on four tests. That finding, said the authors, suggests that diabetes and cognition may be connected via diabetics' vascular problems. For example, diabetes and hypertension may both play a role in a larger metabolic syndrome that includes high blood sugar and insulin resistance.

However, the other two factors raised new questions. Combined gait and balance had the greatest influence, accounting for between 32 percent and 62 percent of performance on seven cognitive tests. Diabetes might affect the specific nerves that control gait and balance, the authors wrote, or more broadly affect the overlapping brain areas that support both gait-balance and cognition.

Like blood pressure, what people said about their health accounted for about one-third to one-half of performance on five different cognitive tests. Negativity about one's health could reflect related factors such as stress or depression, which did not, in this study, directly mediate between diabetes and cognition. Self-reported health is "an important indicator of ways in which a cluster of health-related beliefs and behaviors can modulate the effect of this disease on cognitive adaptation," Dixon said.

"It's important to pay attention to the health beliefs of older adults, not because they are necessarily accurate or valid indicators of specific health status, but because they might track overall health," Dixon said.

Type 2 diabetes in adults accounts for 90 percent to 95 percent of all diagnosed cases of diabetes, according to the National Institute of Diabetes and Digestive & Kidney Diseases.

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by American Psychological Association, via EurekAlert!, a service of AAAS.

Journal Reference:

McFall et al. Testing covariates of Type 2 diabetes-cognition associations in older adults: Moderating or mediating effects? Neuropsychology, 2010; 24 (5): 547 DOI: 10.1037/a0019246

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.


View the original article here

Saturday, April 23, 2011

Tight blood pressure control for patients with diabetes and coronary artery disease not associated with improved cardiovascular outcomes, study finds

ScienceDaily (Sep. 26, 2010) — Patients with hypertension, diabetes and coronary artery disease who maintained their systolic blood pressure at less than 130 mm Hg did not have improved cardiovascular outcomes compared to patients with usual blood pressure control, according to a study in the July 7 issue of JAMA.

"Hypertension guidelines advocate treating systolic blood pressure (BP) to less than 130 mm Hg for patients with diabetes mellitus; however, data are lacking for the growing population who also have coronary artery disease (CAD)," according to background information in the article.

Rhonda M. Cooper-DeHoff, Pharm.D., M.S., of the University of Florida, Gainesville, and colleagues examined whether patients with hypertension, diabetes and CAD who achieved systolic BP of less than 130 mm Hg would have a reduced risk of cardiovascular events compared with those who managed to keep their systolic BP within the range of at least 130 mm Hg to less than 140 mm Hg. The analysis included 6,400 of the 22,576 participants in the International Verapamil SR-Trandolapril Study (INVEST). For this analysis, participants were at least 50 years old and had diabetes and CAD. Participants were recruited between September 1997 and December 2000 from 862 sites in 14 countries and were followed up through March 2003, with an extended follow-up through August 2008 through the National Death index for U.S. participants.

Patients received treatment with either a calcium antagonist or beta-blocker followed by angiotensin-converting enzyme inhibitor, a diuretic, or both to achieve systolic BP of less than 130 and diastolic BP of less than 85 mm Hg. Patients were categorized as having tight control if they could maintain their systolic BP at less than 130 mm Hg; usual control if systolic BP ranged from 130 mm Hg to less than 140 mm Hg; and uncontrolled if systolic BP was 140 mm Hg or higher. The primary outcome included the occurrence of all-cause death, nonfatal myocardial infarction (heart attack), or nonfatal stroke.

The primary outcome occurred in 12.7 percent (286 patients) of those in the tight-control group, 12.6 percent (249 patients) of the usual-control group, and 19.8 percent (431 patients) of the uncontrolled groups. When evaluating all-cause mortality for the entire follow-up period, after adjustment, risk of all-cause mortality was significantly greater in the tight-control group (22.8 percent) than in the usual-control group (21.8 percent).

"In this observational study, we have shown for the first time, to our knowledge, that decreasing systolic BP to lower than 130 mm Hg in patients with diabetes and CAD was not associated with further reduction in morbidity beyond that associated with systolic BP lower than 140 mm Hg, and, in fact, was associated with an increase in risk of all-cause mortality. Moreover, the increased mortality risk persisted over the long term," the authors write.

"At this time, there is no compelling evidence to indicate that lowering systolic BP below 130 mm Hg is beneficial for patients with diabetes; thus, emphasis should be placed on maintaining systolic BP between 130 and 139 mm Hg while focusing on weight loss, healthful eating, and other manifestations of cardiovascular morbidity to further reduce long-term cardiovascular risk."

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by JAMA and Archives Journals.

Journal Reference:

Rhonda M. Cooper-DeHoff; Yan Gong; Eileen M. Handberg; Anthony A. Bavry; Scott J. Denardo; George L. Bakris; Carl J. Pepine. Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease. JAMA, 2010; 304 (1): 61-68 [link]

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.


View the original article here

Monday, January 31, 2011

CDC: 26 Million Americans Have Diabetes

Title: CDC: 26 Million Americans Have Diabetes
Category: Health News
Created: 1/27/2011 11:00:00 AM
Last Editorial Review: 1/27/2011

View the Original article

105 Million in U.S. Have Diabetes or Prediabetes, CDC Says

Title: 105 Million in U.S. Have Diabetes or Prediabetes, CDC Says
Category: Health News
Created: 1/26/2011 6:05:00 PM
Last Editorial Review: 1/27/2011

View the Original article